Host S-nitrosylation inhibits clostridial small molecule-activated glucosylating toxins

The global prevalence of severe Clostridium difficile infection highlights the profound clinical significance of clostridial glucosylating toxins (1-4). Virulence is dependent on the autoactivation of a toxin cysteine protease (5-9), which is promoted by the allosteric cofactor inositol hexakisphosphate ([InsP.sub.6]) (10-17). Host mechanisms that protect against such exotoxins are poorly understood. It is increasingly appreciated that the pleiotropic functions attributed to nitric oxide (NO), including host immunity, are in large part mediated by S-nitrosylation of proteins (18,19). Here we show that C. difficile toxins are S-nitrosylated by the infected host and that S-nitrosylation attenuates virulence by inhibiting toxin self-cleavage and cell entry. Notably, [InsP.sub.6]- and inositol pyrophosphate ([InsP.sub.7])-induced conformational changes in the toxin enabled host S-nitrosothiols to transnitrosylate the toxin catalytic cysteine, which forms part of a structurally conserved nitrosylation motif. Moreover, treatment with exogenous [InsP.sub.6] enhanced the therapeutic actions of oral S-nitrosothiols in mouse models of C. difficile infection. Allostery in bacterial proteins has thus been successfully exploited in the evolutionary development of nitrosothiol-based innate immunity and may provide an avenue to new therapeutic approaches.
C. difficile infection is the most prevalent cause of hospital-acquired infectious diarrhea and life-threatening colitis worldwide (1-4). Two large exotoxins, TcdA (308 kDa) and TcdB (270 kDa), are secreted from [...]